Pretreatment with oral contraceptives benefit POSEIDON group 1 low prognosis patients during GnRH-antagonist protocol: a propensity score-matched retrospective cohort study
Administering OCs as pretreatment prior to ovarian stimulation using gonadotrophin releasing hormone antagonist protocol appears to be a more favorable approach than waiting for natural menses in low prognosis patients belonging to POSEIDON group 1.
Authors
- Cheng Zeng (ORCID: https://orcid.org/0000-0001-6246-6656)
- Ning Wu (ORCID: https://orcid.org/0000-0001-7790-3599)
- Qing Xue (ORCID: https://orcid.org/0000-0003-4646-4620)
- Jing Shang (ORCID: https://orcid.org/0009-0008-7783-0033)
- Xiuli Yang
- Xin Li (ORCID: https://orcid.org/0009-0004-4556-9628)
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Journal of Ovarian Research
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1186/s13048-025-01613-6
- Citations
- 1
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- National Natural Science Foundation of China